Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: University College London,
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
CMV TCR Gene Therapy Trial
The proposed study will test the feasibility of generating donor-derived cytomegalo virus (CMV)-specific T cells via the ex vivo introduction of a CMV-specific T cell receptor using a GMP grade retrov...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
Study of effectiveness of a smartphone application for quitting smoking
Background and study aims Smartphone-based interventions (in the form of applications or apps) have the potential to help smokers quit smoking. Additionally, due to their being highly assessible, ap...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
Using annual reminders to facilitate uptake of bowel scope screening in previous non-participants: A Randomised Controlled Trial
Background & aims: Bowel cancer is the fourth most common cancer in England, and the second leading cause of cancer deaths. Detecting the disease early is associated with improved chances for surviva...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
Primary care based text-reminders in colorectal cancer screening
Lay summary under review with external organisation
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
University College London,
Update Il y a 5 ans
How does giving a little vs. a lot of information about screening for ovarian cancer based on genetic risk assessment influence thoughts and feelings about taking part in ovarian cancer genetic testing and screening?
Background and study aims Despite progress in early detection and treatment for many cancers, ovarian cancer (OC) remains a leading cause of cancer death in women. The absence of a distinct ‘pre-canc...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
University College London,
Update Il y a 5 ans
Development and evaluation of a patient-reported instrument to monitor oncological and functional outcomes after radical prostatectomy: the true NTH Post Surgery programme
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
CATALYST: Carfilzomib-Thal-Dex in relapsed AL Amyloidosis
Lay summary under review with external organisation
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
A feasibility trial of Power Up
Background and study aims Young people with mental health difficulties need support to ensure their voice is heard during therapy. Evidence suggests that young people want to be actively involved in t...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
University College London,
Update Il y a 5 ans
Pilot study to establish laboratory methods for urine Nerve Growth Factor (NGF) and immunohistochemical staining of the vanilloid receptor (TRPV1) in bladder biopsies, following open label treatment with botulinum neurotoxin type A in patients with neurogenic detrusor overactivity (NDO) and idiopathic detrusor overactivity (IDO)
To establish laboratory methods for detecting changes degrees of bladder stimulation via nerves following treatment with BOTOX in patients with urinary urgency incontinence due either to: neurologica...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
University College London,
Update Il y a 5 ans
A Proof of Principle, Double-Blind, Randomised Placebo-Controlled,Multi-centre Trial of pravaStatin to Ameliorate Early Onset Pre-eclampsia
The aim of the trial is to establish whether pravastatin will lead to a significant reduction of circulating anti-angiogenic factors in women with early-onset pre-eclampsia. To test this hypothesis, w...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
2
3
4
5
6
7
8
9
10
11
Next